Literature DB >> 7947691

Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.

E M Sutkowski1, W J Tang, C W Broome, J D Robbins, K B Seamon.   

Abstract

Several forms of adenylyl cyclase (types I, II, V, and VI) have been expressed using the recombinant baculovirus expression system in Sf9 cells. The activation of type I adenylyl cyclase by forskolin and Gs alpha was not greater than additive. In contrast, there was synergistic activation of type II, V, and VI adenylyl cyclases by Gs alpha and forskolin. Gs alpha potentiated the effect of forskolin on type II adenylyl cyclase to the greatest extent. Type I and II adenylyl cyclases were photolabeled specifically by an iodinated photoaffinity derivative of forskolin ([125I]-6-AIPP-Fsk). Type I adenylyl cyclase was photolabeled efficiently in the absence of Gs alpha, and the addition of Gs alpha only slightly increased the labeling efficiency. In contrast, type II adenylyl cyclase was not photolabeled efficiently in the absence of Gs alpha, and the addition of Gs alpha greatly enhanced the labeling efficiency. Photolabeling of type V and VI adenylyl cyclases was detected only in the presence of Gs alpha. Neither calcium/calmodulin nor G protein beta gamma subunits modulated the photolabeling of type I or II adenylyl cyclases. Another iodinated derivative of forskolin, [125I]-6-IHPP-fsk, bound to Sf9 cell membranes expressing type I adenylyl cyclase with high affinity in a filtration binding assay, and the specific binding was not enhanced by the addition of Gs alpha. In contrast, specific binding of [125I]-6-IHPP-Fsk to membranes expressing type II adenylyl cyclase was detected only in the presence of Gs alpha.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947691     DOI: 10.1021/bi00209a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Differential activation of adenylyl cyclases by spatial and procedural learning.

Authors:  J L Guillou; G M Rose; D M Cooper
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 2.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Regulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VII.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Iain D Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

4.  A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Authors:  Monica Soto-Velasquez; Michael P Hayes; Aktan Alpsoy; Emily C Dykhuizen; Val J Watts
Journal:  Mol Pharmacol       Date:  2018-06-27       Impact factor: 4.436

Review 5.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

6.  Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways.

Authors:  C Klingler; N Ancellin; M B Barrault; A Morel; B Corman
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Fast receptor-induced formation of glycerophosphoinositol-4-phosphate, a putative novel intracellular messenger in the Ras pathway.

Authors:  M Falasca; A Carvelli; C Iurisci; R G Qiu; M H Symons; D Corda
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

Review 8.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

9.  Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling.

Authors:  John A Allen; Jiang Z Yu; Rahul H Dave; Anushree Bhatnagar; Bryan L Roth; Mark M Rasenick
Journal:  Mol Pharmacol       Date:  2009-08-20       Impact factor: 4.436

10.  Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms.

Authors:  Amy S Bogard; Anna V Birg; Rennolds S Ostrom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-12-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.